Alterations in EGFR, either through gene amplification or mutation, are frequently observed in several malignancies, most notably in non-small-cell lung carcinoma (NSCLC), breast cancer, and colorectal cancer [7,8,9,10,11,12]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.